ZFIN ID: ZDB-FIG-211129-8
Zhong et al., 2021 - Predicting and Exploring the Mechanisms of Erzhi Pill in Prevention and Treatment of Osteoporosis Based on Network Pharmacology and Zebrafish Experiments. Drug design, development and therapy   15:817-827 Full text @ Drug Des Devel Ther
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Gene:
Fish:
Conditions:
Anatomical Term:
Stage: Days 7-13
PHENOTYPE:
Fish:
Conditions:
Observed In:
Stage: Days 7-13

Fig. 6 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
EGFP b1212Tg chemical treatment by environment: dexamethasone Days 7-13 cranium osteoblast IFL
b1212Tg chemical treatment by environment: quercetin, chemical treatment by environment: dexamethasone Days 7-13 cranium osteoblast IFL
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
b1212Tg chemical treatment by environment: dexamethasone Days 7-13 cranium bone mineralization disrupted, abnormal
Days 7-13 cranium osteoblast EGFP expression decreased distribution, abnormal
b1212Tg chemical treatment by environment: quercetin, chemical treatment by environment: dexamethasone Days 7-13 cranium bone mineralization process quality, ameliorated
Days 7-13 cranium osteoblast EGFP expression position, ameliorated
Full text @ Drug Des Devel Ther